Med AI Bravo launches clinical validation study for AI spine module

Med AI Bravo has commenced a clinical validation study at the Sestre milosrdnice University Hospital Center in Zagreb, marking an important milestone in the development of its AI-powered diagnostic solutions.

The study will evaluate the company's proprietary lumbosacral spine module, designed to support clinicians through advanced image analysis and decision support. Clinical validation is a key step in demonstrating the safety, performance and clinical value of the technology in a real-world healthcare environment.

The project also represents a significant milestone in Med AI Bravo's ongoing CE and FDA certification processes, supporting the company's objective of bringing clinically validated AI solutions to healthcare providers internationally.

Alongside the spine module, Med AI Bravo has expanded its portfolio with the development of a dedicated neurosurgery module, further strengthening its vision of delivering specialised AI tools that enhance diagnostic accuracy and clinical workflows.

As development and regulatory activities continue, Med AI Bravo remains focused on creating innovative, evidence-based technologies that support clinicians and improve patient care.